Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ketamine and ketamine/nap for treatment of ADNP syndrome and related neurological conditions

Ketamine and ketamine/nap for treatment of ADNP syndrome and related neurological conditions

US Patent 12502363 · Granted Dec 23, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ketamine for treatment of ADNP syndrome and sensory processing deficits2023
Head mounted display nosepiece2022
Techniques for using computer vision to alter operation of speaker(s) and/or mic2022
System and method for multicasting IPSEC protected communications2015
System and method for multicasting IPSec protected communications2012